Spherity Blog

Enabling digital sovereignty, zero trust architectures, resilient digital ecosystems and the UN SDGs

In the W3C Verifiable Credentials (VC) community, concerns arose about privacy and consent, focusing on how VCs differ when used by individuals privately (X2I) versus as employees (X2E).

In May 2025, the Louisiana Board held its second public drug verification exercise—testing VRS, DSCSA Authority & ATP credentials ahead of the May 27 DSCSA exemption deadline. How did it compare to the first? What key insights did participants share?

DSCSA enforcement is finally here after multiple delays, and ATP credentials are essential for compliance, data protection, and cybersecurity. So, how is ATP credential adoption progressing — and where do we stand today?

As the pharma industry moves toward DSCSA compliance, the VRS Provider Network highlights concerns with GLN Allow Lists and how ATP digital credentials address them.

PDG and FDA hosted the first of three DSCSA town halls—explore key points, industry insights, and key takeaways from the session.

Pharma industry updates and key takeaways from the 15th Annual Pharma Serialization & Supply Chain 2025 and HDA DMC 2025.

Trust across jurisdictions remains a challenge due to inconsistent and non-interoperable frameworks. Building on eIDAS 2.0, the EUDI Wallet for Organizations (European Business Wallet) will enable secure, compliant B2B and B2G interactions and strengthen trust across EU supply chains.

If you're in digital credentialing, you're part of a global movement, investing in a future-proof, scalable tech. Let's explore examples!

OCI-conformant digital credentials seamlessly interoperable in public Verification Router Service (VRS) exercise.

With the upcoming DSCSA deadline, 6 of the top 10 pharmaceutical companies in the world have partnered with Spherity to enhance data security.

FDA has been keeping its ear to the ground to understand the industry’s DSCSA readiness.

FDA grants large-scale exemption to trading partners on enhanced drug distribution security (EDDS) and related requirements.

The Louisiana Board surveyed DSCSA readiness (Aug–Sep 2024), a timely move ahead of FDA’s Stabilization Period ending Nov 27, 2024.

Olive oil faces rising demands for transparency & sustainability. Digital Product Passports (DPPs) ensure trust, compliance & market access.

How Digital Product Passports evolve from static data repositories to μERP systems, enabling real-time optimization in cyber-physical ecosys

Read industry updates and key takeaways from the DSCSA Stabilization Period at the HDA Traceability Seminar.

EU's ESPR makes Digital Product Passports essential, driving innovation, loyalty, and supply chain efficiency for fashion brands.

Spherity is featured in Gartner’s Decentralized Identity Market Guidance, highlighting the growing role of decentralized identity solutions.

FDA has granted a selective enforcement delay for small dispensers with the definition of ‘small’ being broader than in previous guidance.